a few people working at a table

Press Releases

Ladenburg Acts as Exclusive Placement Agent in $6 Million Offering for Midatech Pharma PLC

Transaction Information Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP) announced that it has raised $6.0 million...

Ladenburg Thalmann Acts as Financial Advisor to Board of Trustees of Vertical Capital Income Fund in New Investment Advisory Agreement with Carlyle

Transaction Information Ladenburg Thalmann & Co. Inc. served as financial advisor to Board of Trustees of...

Ladenburg Serves Exclusive Roles in Completion of Ra Medical Systems Merger with Catheter Precision and $9.3 Million Financing

Ladenburg acted as the Financial Advisor in the Merger and Exclusive Warrant Inducement Agent and Placement Agent in...

Ladenburg Acts as Exclusive Placement Agent in $10 Million Financing for Midatech Pharma and Exclusive Advisor in Merger Between Bioasis Technologies and Midatech

Transaction Information Merger Bioasis Technologies Inc. (TSX.V:BTI), a multi-asset rare and orphan...

Ladenburg Thalmann Acts as Sole Book-Running Manager and Exclusive Placement Agent for $32 Million Offering for NeuroBo Pharmaceuticals, Inc.

Transaction Information NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) announced the closing of an underwritten...

Ladenburg Acts as Exclusive Warrant Solicitation Agent in $3.12 Million Offering for Kiora Pharmaceuticals, Inc.

Transaction Information Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) announced it has entered into warrant...

Ladenburg Thalmann Acts as Exclusive Financial Advisor to GBS Inc. in its Acquisition of Intelligent Fingerprinting

Transaction Information GBS Inc. (Nasdaq: GBS) announced it has acquired Intelligent Fingerprinting Limited...

Ladenburg Thalmann Acts as Sole Book-Running Manager for Nuwellis, Inc. in its $11.04 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Transaction Information Nuwellis, Inc. (Nasdaq: NUWE) announced the closing of an underwritten public offering...

Ladenburg Thalmann Acts as Manager for Rhythm Pharmaceuticals, Inc. in its $124.8 Million Public Offering

Transaction Information Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM) announced the closing of its public offering...